This site uses JavaScript to accomplish certain tasks and provide additional functionality in your browser. If you are seeing this message, then something has prevented JavaScript from running and may cause issues when using the site. Please enable JavaScript on your web browser.
Skip to main content
COVID-19 Treatment Study COVID-19 Treatment Study
  • Home
  • About the Study
  • COVID-19 Resources
  • Press
  • Contact
COVID-19 TREATMENT STUDY
    • Home
    • About the Study
    • COVID-19 Resources
    • Press
    • Contact
  • Home
  • COVID-19 TREATMENT STUDY
  • Press

Press

President Trump’s taking hydroxychloroquine, but what about the rest of us? (May 28, 2020, TRT World)

HCQ may be effective against COVID-19, but criticism has hampered testing (May 24, 2020, The Advocate)

Amid Hydroxychloroquine Uproar, Real Studies of Drug Are Suffering (May 20, 2020, NY Times)

Hydroxychloroquine Debate Interferes With Recruiting Research Volunteers (May 20, 2020, NPR Morning Edition)

Local trials under way for anti-malaria drug at center of Trump COVID-19 debate (May 20, 2020, KOMONews)

Clinical Trial Enrollment Plummets as Volunteers are Scared Off Coronavirus Drugs Promoted by Trump (May 9, 2020, Seattle Times)

More rigorous study of hydroxychloroquine is getting underway with help of Cook County health researchers (May 8, 2020, Chicago Tribune)

Researchers enrolling COVID-19 patients for treatment trial: Trial is looking at effectiveness of hydroxychloroquine with and without azithromycin. Results expected by July. (April 24, 2020, via UW Medicine and UW Dept. of Global Health)

University of Washington - Department of Global Health

Be boundless

Connect with us:

  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Contact Us
  • Jobs
  • Events
  • News
  • Intranet
  • Donate
  • Accessibility
  • Contact the UW
  • Jobs
  • Campus Safety
  • My UW
  • Rules Docket
  • Privacy
  • Terms
  • Site managed by DGHweb
  • Log in

© 2023 University of Washington | Seattle, WA